SCHEMBL2606299

SCHEMBL2606299

C=CC(=O)Oc1ccc2c(c1)C(Cl)c1cc(OC(=O)C=C)ccc1-2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 4/20 0.41
PDE6D O43924 1/20 0.32
TYMS P04818 1/20 0.31
MAPT P10636 4/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
HPGD P15428 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
EGFR P00533 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
PKM P14618 1/20 0.31
ALOX15 P16050 1/20 0.31
ALOX12 P18054 1/20 0.31
JAK1 P23458 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2122679 0.83 THRB (0.45) THRBTYMSMAPTMEN1KMT2A
SCHEMBL2604673 0.80 THRB (0.49) THRBHPGDEGFRLMNAL3MBTL1
SCHEMBL11253852 0.77 THRB (0.45) THRBPDE6DTYMSMAPTMEN1
SCHEMBL11225929 0.77 THRB (0.47) THRBTYMSMAPTMEN1KMT2A
SCHEMBL819722 0.76 THRB (0.53) THRBMAPTMEN1KMT2ASMN1; SMN2
SCHEMBL15338917 0.75 THRB (0.46) THRBPDE6DTYMSMAPTMEN1
SCHEMBL15338966 0.75 THRB (0.42) THRBPDE6DTYMSSMN1; SMN2KDM4E
SCHEMBL2606301 0.74 LMNA (0.34) LMNA
SCHEMBL9607789 0.74 THRB (0.45) THRBTYMSMAPTMEN1KMT2A
SCHEMBL11241551 0.74 THRB (0.49) THRBPDE6DTYMSMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394468-B2 Polymerizable compound and liquid crystal composition including it JNC CORPORATION (JP) 2013-03-12 US disclosed
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT JNC PETROCHEMICAL CORPORATION (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT KLK3, PDE7A, FZD7 THRB 4883/4885PDE6D 116/4885TYMS 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.